Related Experiment Videos
[Prognosis and life expectancy in multiple sclerosis]
1Neurologischen Klinik, Universität München.
Versicherungsmedizin
|April 1, 1991
Summary
Multiple sclerosis prognosis can be assessed by disability and disease progression. Despite a potential 10-15 year reduction in life expectancy for multiple sclerosis patients, life insurance options should be explored.
Area of Science:
- Neurology
- Medical Prognostics
Context:
- Multiple sclerosis (MS) is a chronic neurological disease.
- Assessing prognosis and life expectancy in MS patients is crucial for management and planning.
Purpose:
- To evaluate the factors influencing prognosis and life expectancy in multiple sclerosis.
- To determine the feasibility of life insurance for individuals with MS.
Summary:
- Prognosis and life expectancy in multiple sclerosis can be determined through regular examinations of disability status, disease duration, and disease course.
- It is estimated that life expectancy for MS patients is collectively reduced by 10 to 15 years.
- The study suggests that securing life insurance for multiple sclerosis patients should be achievable.
Impact:
- Provides insights into the long-term outlook for multiple sclerosis patients.
- Highlights the potential for improved financial planning and life insurance accessibility for individuals with MS.
- Informs healthcare providers and insurers about the life expectancy considerations in multiple sclerosis.